Home › Stargardt Disease › Massachusetts
Stargardt Disease clinical trials in Massachusetts
4 studies for Stargardt Disease are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Massachusetts Eye and Ear, Boston
- Boston Children's Hospital, Boston
RecruitingObservational study
Ages 5 and older · All sexes · Updated Oct 9, 2026 · NCT06445322Study of ALK-001 on the Progression of Stargardt Disease
- Tufts Medical Center - New England Eye Center, Boston
RecruitingPhase 3
Ages 8 to 45 · All sexes · Updated Sep 18, 2026 · NCT07419334An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Massachusetts Eye and Ear Infirmary, Boston
RecruitingObservational study
Ages 12 to 65 · All sexes · Updated Sep 19, 2025 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Massachusetts Eye and Ear Infirmary, Boston
RecruitingPhase 1/2
Ages 12 to 65 · All sexes · Updated Apr 29, 2025 · NCT06942572From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.